POPULARITY
Categories
Dr. William Li is a Harvard-trained physician, co-founder of the Angiogenesis Foundation, and New York Times bestselling author whose work centers on one quietly radical premise: the power to stay healthy lives inside you. In this conversation, we explore the five hardwired defense systems the body runs continuously, angiogenesis, stem cells, the gut microbiome, immunity, and DNA protection, and what it looks like to actually support them through food, sleep, and daily choices.What We Dive Into:1. You are not just one organism. You carry 39 trillion bacteria inside you, many of which send signals up through the vagus nerve directly to the brain, shaping mood, social behavior, and stress levels.2. Your body was born with 70 million extra stem cells stored in bone marrow, ready to mobilize and repair damage whenever called. Sleep, food, and metabolic health directly influence how effectively they do their job.3. The environment is full of things we cannot fully control, microplastics, toxins, pollution. What we can control is whether our internal defense systems are strong enough to handle the load. Chronic stress degrades those systems faster than most environmental exposures.Know Thyself, but not by yourself. A guided space to return home to yourself.https://www.knowthyselfcollective.com✨THANK YOU TO OUR SPONSORS:https://drinkLMNT.com/KnowThyselfTry LMNT & get a free sample pack https://oneskin.co/KNOWTHYSELFCode KNOWTHYSELF for 15% off___________00:00 Intro01:42 Health Is Not the Absence of Disease05:24 The Five Health Defense Systems07:14 Defense 1: Angiogenesis and Blood Vessel Health09:07 Defense 2: Stem Cells and the Body's Repair System14:01 Defense 3: The Gut Microbiome and the Holobiont21:38 Defense 4: The Immune System as Inner Army31:44 Defense 5: DNA Repair and the Iron Dome Within36:48 Cancer Is Growing in All of Us Right Now43:07 The Rising Cancer Rates and Why They're Skewing Younger47:40 Microplastics: Where They Come From and Why They Matter55:37 The Case for Keeping Your Shields Up59:15 Practical Steps: Air, Water, and Food Quality1:07:46 Sleep, Movement, and Stress as Health Defenses1:11:04 The Danger of Chronic Overeating1:19:09 The History of Abundance and the Clean Plate Myth1:23:43 Bruce Lee and the Philosophy of Personalized Health1:29:00 What Modern Medicine Got Right and What It Lost1:32:42 The Interstitium, Acupuncture, and Converging Worlds1:35:34 The Future of Cancer Treatment and Health Span1:44:42 Dr. Li's Favorite Foods and Why He Loves Them1:55:53 The Science of Dark Chocolate1:59:00 Closing Message: Optimize Your Gut___________✨MORE FROM DR. WILLIAM LI↳Instagram: https://www.instagram.com/drwilliamli/↳Facebook: https://www.facebook.com/drwilliamli/↳YouTube: https://www.youtube.com/c/DrWilliamLi↳Eat to Beat Your Diet Book: https://drwilliamli.com/etb-diet-book/↳Eat to Beat Disease Book: https://drwilliamli.com/book-li/↳https://drwilliamli.com
This conversation was originally recorded and published in November, 2024. In light of Richard's passing, we wanted to share it again because his insights remain as inspiring and relevant as ever. We extend our deepest condolences to his family, friends and colleagues.
Most people undergoing cancer treatments know to watch out for fatigue or hair loss, but far fewer expect the severe impact of oral mucositis. While it often begins as a painful side effect of chemotherapy or radiation, severe cases can rapidly cross the line into a critical oncology emergency.Learn why Stage 4 mucositis becomes a medical emergency and about life-threatening complications like sepsis, severe dehydration, and treatment interruptions. Then, we share a rebroadcast of our comprehensive guide with daily steps patients can take to protect their mouths, manage symptoms early, and preserve their quality of life.https://bit.ly/3Tqfl18 for helpful visuals, resources, and a mouth rinse recipeTimestamps:00:00 - Mucositis - What it is and Why it Can Become a Cancer Emergency07:34 - Intro S6E22 Mucositis with Cancer Treatment and How You can Prevent It09:18 - The Sharks of Rockaway Beach13:50 - Road Trip to Nebraska - Famous Murder Spree and Reuben Sandwich17:59 - Oral Mucositis - Common Symptom of Cancer Treatment21:24 - Why it is Important to be Proactive to Prevent Mucositis29:05 - Mucositis Discussion34:18 - Nutrition Tips for dehydration, taste changes and decreased appetite or pain while eating36:18 - Holly Butcher: Advice to World 24 Hours before She Died of Cancer38:16 - Outro with words from Killian Murphy#OncologyEmergency #OralMucositis #CancerCaregiver #ChemotherapySideEffects #CancerSupport #PatientEducation #SupportiveOncology #SepsisAwareness #MouthSoresSupport the show
A new study by ChristianaCare looked at how AI-generated avatars could help patients be more prepared for cancer treatment visits.The patients engage with an avatar of the actual doctor they will meet with, to help them be more comfortable when actually meeting the doctor for the first time.In this edition of Enlighten Me, Delaware Public Media's Joe Irizarry discussed this new way of helping patients and the study looking at the program, with Adam Raben, M.D., Chair of Radiation Oncology at ChristianaCare's Helen F. Graham Cancer Center & Research Institute.
Can focal therapy truly “thread the needle” between active surveillance and radical prostate cancer treatment? In this episode of BackTable Urology, host Dr. Tiwa Akinsola is joined by Dr. George Schade from the University of Washington to explore focal therapy as a middle ground between active surveillance and radical treatments. Dr. Schade reviews non-radiation energy modalities including HIFU, TULSA/HI-DU, cryotherapy, and irreversible electroporation, highlighting patient selection, institutional experience, technical nuances, and quality-of-life outcomes from recent trials. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps00:00 - Introduction02:09 - Overview of Focal Therapy Modalities04:46 - Deciding Between HIFU and IRE06:56 - Evidence and Trials09:40 - Counseling Patients on Outcomes12:09 - Building a Focal Therapy Program16:12 - Navigating Insurance and Appeals21:48 - Managing Large Glands And TURP25:12 - Preop Workup Essentials and OR Workflow32:32 - Overcoming the Learning Curve35:52 - PostOp Recovery and Surveillance39:04 - Options for Managing Recurrence42:44 - Challenges with Repeat Ablation44:56 - Final Takeaways --- More about this episodeThe conversation covers candidate selection and confirmatory biopsy, perioperative technique and recovery, and ongoing surveillance with PSA, MRI, and biopsy. Dr. Schade also discusses challenges with insurance approvals, building a focal therapy practice, and options for managing recurrence, including repeat ablation, surgery, or radiation. The episode examines how to balance cancer control with quality of life and reviews the evolving evidence base supporting focal therapy's role in prostate cancer treatment. --- Resources Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE Trial:https://www.sciencedirect.com/science/article/pii/S030228382500346X Focal therapy of localized prostate cancerhttps://pubmed.ncbi.nlm.nih.gov/35996758/ Focal Therapy for Prostate Cancer: Available Technologies, Patient Selection, Follow-Up Protocols and Reported Outcomeshttps://pubmed.ncbi.nlm.nih.gov/41339218/ --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.► https://www.backtable.com/app
Send us Fan MailFor decades, the war on cancer has focused on destroying cancer cells directly - with chemotherapy, radiation, and targeted drugs. But what if the future of cancer treatment is not about attacking cancer ourselves...but teaching our own immune system to do it for us?Today we're exploring a new generation of immunotherapies designed to turn the body's own defenses into a precision weapon against cancer.Over the past decade, immunotherapies such as checkpoint inhibitors and CAR-T cell therapies have transformed the treatment landscape for many cancers. But major challenges remain - including limited response rates, treatment resistance, toxicity, and the enormous complexity and cost of manufacturing many next-generation therapies.Our guest today believes the next breakthrough may come from a new generation of personalized immunotherapies designed to activate a patient's own immune system against their cancer - while also being manufactured as an accessible, off-the-shelf treatment.Joining us is Dr. William Williams, MD - President and CEO of BriaCell Therapeutics ( https://briacell.com/ ).Dr. Williams brings more than 35 years of experience spanning academia and the biopharmaceutical industry. He has helped advance numerous medicines from discovery through clinical development, including work contributing to therapies such as Jakafi and Olumiant during his time at Incyte, and multiple oncology programs during his career at GlaxoSmithKline.Before entering industry leadership, Dr. Williams was a researcher at the University of Pennsylvania focused on molecular immunology, receptor biology, and early DNA vaccine approaches.Today we'll discuss the evolution of cancer immunotherapy, BriaCell's Bria-IMT platform, the challenges of treating advanced breast cancer, and whether the future of oncology lies in creating therapies that can truly mobilize each patient's own immune system.#CancerResearch #CancerImmunotherapy #Immunotherapy #CancerTreatment #Oncology #PrecisionMedicine #PersonalizedMedicine #Biotechnology #Biotech #LifeSciences #DrugDiscovery #ClinicalTrials #BreastCancer #MetastaticBreastCancer #CancerVaccine #CellTherapy #TumorImmunology #TCells #ImmuneSystem #MedicalInnovation #FutureOfMedicine #HealthcareInnovation #BiomedicalResearch #Pharma #PharmaceuticalInnovation #SciencePodcast #ProgressPotentialAndPossibilities #PPPShowSupport the show
When we talk about EMF and cancer, the conversation usually focuses on risk. But what if electromagnetic fields could actually help treat cancer? In this episode, I break down a fascinating new study showing how pulsed electromagnetic field therapy altered the genetic profile of bladder cancer cells in the lab -- and what this tells us about the complex relationship between EMF and human biology. This isn't about fear. It's about understanding how the same technology that requires caution in one context might offer therapeutic benefits in another. In This Episode How pulsed electromagnetic fields changed gene expression in bladder cancer cells Why the same technology that poses risks can also treat disease What FDA-approved cancer treatments already use electromagnetic fields The key difference between therapeutic EMF and everyday exposure Featured Study Read the full study: Pulsed Electromagnetic Field Therapy Alters the Genomic Profile of Bladder Cancer Cell Line HT-1197 See all studies at shieldyourbody.com/research
June 10, 2026 ~ 'JR Morning co-hostJamie Edmonds gives an update on her cancer treatment and talks about the latest episode of ‘Jamie's Journey. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.
Dr. Mitch Shulman can be heard every weekday morning at 7:50 on The Andrew Carter Morning Show.
New research has revealed that women are enduring pain and discomfort from gynaecological side effects from cancer treatments due to the stigma associate with the conditions. In this edition of The Conversation Hour we speak with the report author about the need for health care workers to be more proactive in discussing the side effects, to ensure their patients health and wellbeing.Also in this edition, a rise of delivery drivers being scammed, how AI is impacting the media landscape, plus, the blurring of reality tv and documentary.
This interview is disseminated on behalf of Medicus Pharma Ltd.With Phase 2 studies moving forward across its clinical programs, Medicus Pharma (NASDAQ: MDCX) is also planning to evaluate the use of its SkinJect anti-skin cancer patch to combat Gorlin Syndrome, a rare genetic disorder, as well as Teverelix for the potential treatment of endometriosis.Executive Chairman and CEO Dr. Raza Bokhari shares more details about the company's FDA application to test SkinJect in Gorlin Syndrome patients, its genomics-enabled clinical trial in Abu Dhabi for Teverelix's use in endometriosis, and anticipated growth milestones, including potential strategic partnerships.Learn more about Medicus Pharma: https://medicuspharma.com/Watch the full YouTube interview here: https://youtu.be/v_ZhrQE2DFMAnd follow us to stay updated: https://www.youtube.com/GlobalOneMedia
Jennifer Rosenblad and Amy Appold are best friends who live in Columbia and have both survived breast cancer. They spoke about the benefit of knowing other survivors who fully understand the challenges of treatment, as well as about how community support was important during their experiences.
In today's episode, we spoke with David O'Malley, MD. Dr O'Malley is a professor in the Department of Obstetrics and Gynecology at The Ohio State University College of Medicine and the director of the Division of Gynecologic Oncology at The Ohio State University Comprehensive Cancer Center–James in Columbus, Ohio. In our exclusive interview, Dr O'Malley discussed his approach to treatment selection and sequencing in platinum-resistant ovarian cancer, a disease setting he described as representing the highest unmet need in the field. He emphasized the central role of clinical trial enrollment and biomarker-driven decision-making, alongside practical patient-centered considerations, such as infusion schedule and quality of life.He highlighted the growing importance of antibody-drug conjugates (ADCs) in this setting, noting that folate receptor alpha and HER2 are the two biomarkers most relevant to current practice. Dr O'Malley outlined how National Comprehensive Cancer Network guidelines support treatment across a broader range of expression levels than initial approvals reflected, citing emerging data suggesting activity even at lower expression thresholds. He also addressed payload sequencing, explaining that outside of a clinical trial, he currently uses topoisomerase I–based ADCs and antimicrotubule-based ADCs each one time only, and remains open to targeting the same antigen again if the payload differs.The discussion also touched on combination strategies, resistance biology, and the evolving role of immunotherapy following the survival benefit observed with pembrolizumab (Keytruda) in the phase 3 KEYNOTE-B96 trial (NCT05116189). Dr O'Malley expressed enthusiasm for next-generation payloads, dual-target approaches, and the potential for bispecific antibodies and novel DNA damage response–targeting agents to define the post-ADC treatment landscape.Finally, Dr O'Malley underscored the need for more tumor biopsies to better characterize resistance mechanisms and called for expanded pharmaceutical investment in retreatment and cross-resistance studies to guide future sequencing decisions.
Thank you for joining us for our 2nd Cabral HouseCall of the weekend! I'm looking forward to sharing with you some of our community's questions that have come in over the past few weeks… Amy: Hi Dr Cabral. Many thanks for all that you do for this community! I'd love your advice on anal fissures. I had one recently that had begun healing. My doctor gave me Diltiazem/Lidocaine cream that I used 2x day and my fissure closed and developed healing/scar tissue. However, less than 2 months later, it's opened again. His suggestions previously involved either Botox injections or surgery if the cream had not worked and I would prefer to try and address it more naturally. Do you have any suggestions about what I can do to get this fissure to heal and stay healed naturally? I'm working on diet/fiber but that doesn't seem to be enough. One bad bout of constipation and it seems to undo anything I've done to help. Thanks! Anonymous: Hi Dr. Cabral. This is a bit of an intimate question. I'm having some sort of reaction after I have sexual intercourse. I get a prickly, itchy, warm sensation in my vagina, on my legs and stomach. Sometimes red bumps appear on my skin. Almost like I'm having an allergic reaction. Symptoms continue on and off for about 3 or 4 days then everything calms down and goes back to normal. It seems to happen more around ovulation and menstruation but recently happening anytime of the month. Any idea what is happening to me and what I can do to heal it?! To note, I'm 40 years old, still getting regular periods. Thank you for your help! Mke: Hi Dr Cabral, would love your thoughts. I have known for a year I've had silicosis & PMF (progressive massive fibrosis) I was misdiagnosed for the last 15 years they've told me I've had sarcoidosis. My wife is an IHP, and we have been doing foundational protocols/DNS/detoxes/heavy metal detox/saunas/coffee enemas etc for the past 3 years. I have a very physical job and do keep my cardio fitness up, which seems to help my breathing. We have just invested in a home soft shell hyperbaric chamber after speaking to a guy in the US who's lung function has dramatically improved (he has silicosis but not PMF) as well as investing in a rife machine. Do you have any advice, thoughts or info on slowing down or reversing scarring or anything that might help? Jamie: My daughter, nearly seven, has developed severe hay fever this year in the UK. She is constantly sneezing, has dark circles under her eyes, looks exhausted for almost three months, and her sleep, breathing, concentration and focus seem affected. She may also have a mild dairy intolerance, possibly linked to eczema in her inner elbows, though otherwise she is active and well. We also suspect slightly restricted sinus passages and mouth-breathing, and are considering seeing a functional-medicine-style dentist to support facial/skull development. Could you advise on practical ways to help her and whether any allergy or other tests would be worthwhile at her age to identify the root cause? Any initial guidance hugely welcome. Massive thank you to you your family and your team. Sarah: Last year I was diagnosed with stage 4 grade 3 endometrial cancer. I underwent six rounds of chemotherapy: Paclitaxel and carboplatin along with immunotherapy; jemperli. I also had a complete hysterectomy after the third round. Prior to treatment I had regular bowel movements. Now they are loose and very dark brown. I have very limited resources currently. What do you suggest I do to heal my gut? Thank you for tuning into this weekend's Cabral HouseCalls and be sure to check back tomorrow for our Mindset & Motivation Monday show to get your week started off right! - - - Show Notes and Resources: StephenCabral.com/3796 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!
Gordon Flannery has had a year that nobody would want to go through. The Ennis native, who is a publican in Listowel, Co. Kerry, received a colon cancer diagnosis in September of last year, and was told that he had just three months to live. Gordon was extremely close to death when he underwent life-saving open bowel surgery in The Mater Hospital in Dublin to remove most of the tumour blocking his colon. Gordon joined Alan Morrissey to share his story, and to encourage men to get checked. Photo (c) Clare FM
What do you do when Y-90 doesn't deliver the results you expected? In this episode of the 2026 HCC Creator Weekend™, host Dr. Tyler Sandow is joined by Drs. Beau Toskich and Juan Gimenez to discuss the technical challenges and troubleshooting strategies that can make or break a Y-90 radioembolization case. Together, they explore innovative approaches like the PREDATr technique, share tips for reducing complications, and offer guidance on optimizing outcomes for patients with complex liver tumors. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported by an educational grant from Sirtex and Boston Scientific. --- Timestamps 00:00 - Introduction04:24 - Treatment Nonresponse Troubleshooting06:12 - Navigating Y90 Through Replaced Arteries09:09 - Mitigating Vasospasm in Embolization13:31 - What is ‘PREDATr'?21:12 - Dual Balloon Microcatheter System23:37 - Gelfoam Techniques and Application26:06 - Embolization Agents Preferences36:16 - Concerns with Cystic Artery Treatment and Biliary Stents42:15 - Prophylactic Antibiotics 44:29 - Utilizing High Lung Shunts49:28 - Wrap Up and Credits --- More about this episode The conversation begins with case-based examples of HCC radioembolization, focusing on how to assess treatment response and troubleshoot nonresponsive cases. They discuss how to interpret SPECT findings, identify missed tumor supply with cone-beam CT, and overcome obstacles such as vasospasm, extrahepatic feeders, and challenging arterial anatomy. They introduce the PREDATr technique (proximal radioembolization enabled by distal angiozone truncation) and explain how tools like gelfoam, balloons, and retrievable coils can preserve healthy liver tissue and improve microsphere delivery. The episode also addresses managing biliary stents, using antibiotic prophylaxis, and strategies for handling high lung shunts, making it a practical resource for anyone navigating the complexities of Y-90 treatment. --- BackTable Vascular & Interventional (VI) is the go-to podcast for interventional radiologists, vascular surgeons, and interventional cardiologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
Not all vitamins work the same. What if the difference between helping your child heal… and unintentionally holding them back… comes down to how you're using something as simple as vitamin C or D? In this episode, we're talking about two of the most commonly used nutrients in cancer care(vitamin C and vitamin D) and why dose, source, and strategy matter more than most people realize. This conversation comes from a live office hours session with Dr. Charles Pennick, where we walk through how these nutrients actually function in the body, the difference between synthetic and whole-food forms, and how to think about dosing safely, especially during active treatment. We also explore the nuances that often get missed: why vitamin C isn't just ascorbic acid, how high-dose IV vitamin C works differently than oral forms, and why pairing vitamin D with K2 is essential for proper absorption and safety. If you've ever felt confused about supplements—or wondered if you're doing "too much" or "not enough". This episode will help you approach these foundational nutrients with more clarity and confidence. LINKS Guest Links Website: https://www.drcharlespenick.com/about Recommended Tools & Resources: Fullscript (Practitioner-Grade Supplements): If you're looking for high-quality, practitioner-grade supplements to support your health, Season has created a hand-curated Fullscript dispensary with the exact products she trusts and uses in practice. You'll also get 15% off your first order + 5% off for life as a podcast listener. Access it here: https://bit.ly/seasonsfullscript Community & Support: Thrive through and beyond formula program: https://biodynamicwellness.com/kids-cancer-support Join Thrive Through Cancer Community: https://biodynamicwellness.com/services Connect with Season: Website: www.seasonjohnson.com Instagram: @seasonjohnson
The first uterine transposition, a minimally invasive surgery that temporarily relocates your uterus into your upper abdomen, was performed in Canada on a young woman in Montreal earlier this year. The surgery was designed to help young women battling specific types of cancer around the pelvic area preserve their fertility, which is typically lost during radiation therapy. We speak with Dr. Reitan Ribeiro, who pioneered this surgery in 2017 and performed the first surgery in Canada this year, and Denise Maradona, an early patient of Dr. Ribeiro's who received one of the first ever uterine transpositions in Brazil back in 2018.
In this episode of Medical Matters Podcast, the doctors discuss the strides science has made in the treatment of cancer. An overview of cancerous cells and tumors is provided, along with early treatments, of which there were few. There are four categories of cancer treatment. These methods include precision medicine, and personalized vaccines, radiotherapy, and diagnostics are also examined; the latter may further be assisted by Artificial Intelligence.Recently, a new treatment for pancreatic cancer has been found to double survival time and can be found at Health.com. Another recent potential breakthrough came from research conducted at Cornell University.Today's discussion will also demystify some of the concerns about cancer, its various forms, and the treatments now available.
CAR-T cells developed from bone marrow donors whose bone marrow had already been used to treat someone's cancer may be able to rein in cancer recurrence, a new study finds. Johns Hopkins Kimmel Cancer Center director William Nelson says this … Can donor CAR-T cells have an impact on cancer treatment? Elizabeth Tracey reports Read More »
"Horse Paste" and other anti-parasitics are showing incredible results with repurposed treatment in over 400 studies. It's time to rethink cancer treatment.I also recommend you get a X Account and begin following these doctors.Dr. John Campbell on Study with +84% Positive Resultshttps://x.com/rcjdpoctner/status/2064048411347689806?s=43Dr John Campbell and Dr. William Makis on Dosageshttps://x.com/genixmeds/status/2064004271289565401?s=12Dr. William Makis on Shannon Joy Discussing Mechanisms of Causehttps://x.com/mcgillmedicines/status/2064158092342808710?s=43Joe Tippins Testimonyhttps://x.com/joetippen/status/2064348701942808577?s=43Dr. Ilyes Baghli - Stage 4 Brain Cancer Storyhttps://x.com/skymeds_store/status/2063940098975240471?s=43Dr. Thomas Lodi on Causative Mechanismshttps://x.com/joetippens_/status/2066783804711137338?s=43Other Links of Interesthttps://x.com/valerieanne1970/status/2064165586758926475?s=43https://x.com/joetippen/status/2064703874804355278?s=43https://x.com/nichulscher/status/2065817143971639686?s=43https://x.com/zakariamdv3/status/2066594630926467573?s=43
This Men's Health Month, Navigating Cancer TOGETHER sits down with Clarence Jones, prostate cancer survivor and one of Minnesota's most trusted names in community health.Clarence Jones, MA, CHW, CPH, CPE, is the Executive Director and Community Health Strategist of the Hue-MAN Partnership, a founding member of the organization he helped build into one of Minnesota's most trusted voices in public health. He serves as an Adjunct Instructor of Medicine at Mayo Clinic, is a founding member of the Minnesota Fathers and Families Network, has served as the Mayor's Representative and co-chair of the Public Health Advisory Committee for the City of Minneapolis, and holds affiliations with the CTSI Executive Leadership team and the University of Minnesota's CEARCH initiative. He is also a fatherhood doula, the host of the Community Health Dialogue radio show on KMOJ 89.9 FM, and co-host of the Health Chatter podcast.In this warm, honest, and personal conversation, Clarence opens up about his own journey through prostate cancer, from watching his PSA numbers climb year after year and practicing watchful waiting, to eventually choosing surgery. He shares why the digital exam scares men, and why early detection is the greatest gift you can give your family.But Clarence's story doesn't stop at survival. He shares how his experience deepened his mission to make sure the men and families in his community have access to credible, culturally relevant, evidence-based health information. That's the heartbeat of everything Hue-MAN does.You'll also hear him talk about what he wants every man facing a cancer diagnosis to know right now.✨ Episode Highlights:00:04:38 The Moment He Knew: Clarence's Prostate Cancer Journey00:09:22 How to Invite Men into Health Conversations Without Lecturing Them00:14:44 What Young Men Need to Know About PSA Screening and Biopsies00:27:45 Fatherhood Doula: What That Means and Why Fathers Matter00:36:55 What 'Navigating Cancer TOGETHER' Really MeansTranscript: https://bit.ly/podscript184Connect & Engage with ClarenceWebsite: www.huemanpartnershipalliance.orgHealth Chatter Podcast: www.healthchatterpodcast.comKMOJ Community Health Dialogue: 89.9 KMOJ FM
What if some of the most promising discoveries in cancer research were hidden from public view? Discover how plant-based compounds may help support healthy cells and why addressing root causes matters in cancer prevention and recovery. Join me and my guest, Sylvie Beljanski, President of The Beljanski Foundation, to learn more about her father's pioneering work in molecular biology, his discovery of plant extracts that selectively target cancer cells, and the remarkable story behind a research legacy that continues today.
Dr. Karen Mustian is an energetic, passionate scientist, world traveler, yogi, scuba diver, and foodie whose life's work is dedicated to improving the quality of life of individuals affected by cancer. Through her research, leadership, and advocacy, she strives to help cancer patients and survivors not only live longer, but live better.Dr. Mustian is a Dean's Distinguished Professor in the Department of Surgery at the University of Rochester Medical Center and an internationally recognized leader in Cancer Survivorship, Integrative Oncology, Exercise Oncology, Geriatric Oncology, Behavioral Oncology, and Gender, Sexuality, and Women's Health.She serves as Associate Director for Population Science at the Wilmot Cancer Institute, Director of the University of Rochester Cancer Center NCI Community Oncology Research Program Clinical Trial Network and Founding Director of the PEAK Human Performance Research Laboratory at the University of Rochester Medical Center. She is also a Faculty Associate with the Susan B. Anthony Institute for Gender, Sexuality, and Women's Studies.At the national level, Dr. Mustian serves on the National Cancer Institute Cancer Advisory Board Working Group for Extramural Research Concepts and Programs and the National Cancer Institute Symptom Management and Quality of Life Steering Committee, where she helps shape the future of cancer research and supportive care. Dr. Mustian has secured more than $145 million in peer-reviewed research funding and ranks among the most highly NIH-funded researchers in the United States. She has authored more than 250 scientific publications and is widely recognized for her pioneering contributions to oncology research, supportive care, and clinical trial innovation.Her accomplishments have been honored with more than 45 national and international awards, including recognition as a Fulbright Scholar, recipient of the ASCO Walther Supportive Oncology Lifetime Achievement Award, and recipient of the Prime Minister's Yoga Award for her transformative impact on yoga research worldwide. Dr. Mustian is best known for advancing evidence-based, integrative approaches to cancer care. Through groundbreaking research on yoga, tai chi, mindfulness, and exercise, she has helped establish non-pharmacologic interventions as effective strategies for reducing treatment- related toxicities, improving symptom management, and enhancing the health and well-being ofcancer patients and survivors around the globe.Support the show
Are you in control of your health? Allergies Allopaths vs homepaths Heart Disease & Cancer- Docs views on Cancer Treatment ... you'd be shocked Can you find your true north ... or is intuition gone? Has health care become the watering hole for the rich elite? Reduce variables to get answers
EVEN MORE about this episode!Join Julie Ryan for a powerful episode of the Ask Julie Ryan Show featuring live intuitive scans, energetic healings, and inspiring stories of resilience. From Australia to Connecticut and beyond, callers bring questions about chronic pain, brain cancer recovery, vision concerns, pet health, and emotional healing.A particularly moving conversation with Tracy, who is navigating brain cancer treatment, highlights the extraordinary power of hope, visualization, and collective intention. Along the way, Julie demonstrates her unique healing techniques, explores the connection between emotional and physical well-being, and reminds listeners that healing can happen on many levels.Whether you're seeking healing, supporting a loved one, or simply curious about the role of energy and intention in wellness, this episode offers inspiration, practical insights, and a powerful reminder that no one has to face life's challenges alone.Episode Chapters:(0:00:01) - Ask Julie Ryan Show(0:14:40) - Cancer Healing Energy Session With Tracy(0:23:56) - Healing Energy for Eye Conditions(0:36:54) - Healing Group Session for Hearing Loss(0:49:54) - Pet Health and Healing Consultation(0:59:09) - Healing Energy for Cancer Treatment(1:05:36) - Healing Messages From Sweet Home Alabama➡️ Subscribe to Ask Julie Ryan YouTube➡️ Julie's Intuitive Trainings✏️ Ask Julie a Question!
What if a cancerous tumour could be destroyed without a single incision, stitch or scar? A Singapore grandfather waiting for a liver transplant has become one of the first patients in Southeast Asia to undergo a breakthrough treatment called histotripsy - a technology that uses focused sound waves to destroy a liver tumour. Could this be a glimpse into the future of medicine, where cancer treatment becomes less invasive? Hosted by Michelle Martin, this episode explores the science, the human story and what innovations like histotripsy could mean for longevity and the future of cancer care. Send this episode onto someone who needs a boost of hope. Guest: Prof Brian Goh, Head of Department of Hepato-pancreato-biliary and Transplant Surgery, SGH & NCCS, and Principal Investigator of the HALT Study.See omnystudio.com/listener for privacy information.
What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology, Dr. Kelly Bree, Dr. Saum Ghodoussipour, and Meredith Donahue, N.P., join host Dr. Vignesh Packiam to discuss the power of shared decision-making across the NMIBC spectrum. They explore risk-adapted treatment selection, when to escalate or de-escalate therapy, and how to navigate conversations about recurrence risk, treatment burden, quality of life, and the possibility of cystectomy. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported by an educational grant from Johnson & Johnson. --- Timestamps 00:00 - Introduction01:55 - Second Opinions and Patient Counseling06:08 - Intermediate Risk Stratification12:13 - Treatment Options for Intermediate Risk NMIBC16:20 - BCG and Alternative Treatments for High Risk NMIBC26:49 - Options for BCG-Unresponsive NMIBC31:42 - Sequencing and Cystectomy37:03 - Financial and Time Toxicity41:08 - Biomarkers and ctDNA44:04 - Future Trials and NMIBC Innovations --- More about this episode They also review emerging therapies such as ZUSDURI, the evolving role of intravesical treatments, and the promise of biomarkers and ctDNA for personalized care. The discussion covers practical strategies for patient counseling, key updates to clinical guidelines, and a preview of innovations shaping the future of NMIBC management. --- Resources Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial:https://pubmed.ncbi.nlm.nih.gov/41571573/ Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non–Muscle-Invasive Bladder Cancerhttps://ascopubs.org/doi/10.1200/JCO-25-01324 CIRCULATING TUMOR DNA AS A BIOMARKER FOR UPSTAGING AND ADVERSE PATHOLOGY IN HIGH-RISK NON–MUSCLE-INVASIVE BLADDER CANCER:https://www.auajournals.org/doi/abs/10.1097/01.JU.0001191388.74345.c9.09 Preoperative Circulating Tumor DNA Predicts Upstaging and Recurrence in High-Risk Nonmuscle-Invasive Bladder Cancer Undergoing Radical Cystectomyhttps://pubmed.ncbi.nlm.nih.gov/41843048/ --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
Sign up for Dr Matt's FREE substack:https://substack.com/@connectiondocs Join Chef AJ's Exclusive Plant-Based Community. Become part of the inner circle and start simplifying plant-based living - with easy recipes and expert health guidance. Find out more by visiting: https://community.chefaj.com/ ORDER MY NEW BOOK SWEET INDULGENCE!!! https://www.amazon.com/Chef-AJs-Sweet-Indulgence-Guilt-Free/dp/1570674248 GET MY FREE INSTANT POT COOKBOOK: https://www.chefaj.com/instant-pot-download Disclaimer: This podcast does not provide medical advice. The content of this podcast is provided for informational or educational purposes only. It is not intended to be a substitute for informed medical advice or care. You should not use this information to diagnose or treat any health issue without consulting your doctor. Always seek medical advice before making any lifestyle changes. To book a consultation with Matt: https://form.jotform.com/241997228318164 Matthew Lederman, MD, is a board-certified Internal Medicine Physician and a pioneering thought leader in holistic health. Renowned for his innovative integration of plant-based nutrition, Nonviolent Communication (NVC), trauma-informed care, and lifestyle medicine, Dr. Lederman's work highlights the profound interconnectedness of physical, emotional, and relational well-being. As a certified Nonviolent Communication Trainer through the Center for Nonviolent Communication (CNVC), Dr. Lederman combines Polyvagal Theory, Somatic Awareness Principles, and Pain Reprocessing to empower individuals to heal from within. His approach helps people address the root causes of chronic health challenges, fostering emotional resilience and cultivating meaningful connections. Email:Support@ConnectionDocs.com Website: https://www.connectiondocs.com/ Free Resources (includes Feelings & Needs Sheet for children AND Role-Play Video “Talking to Your Child About ‘Too Much' Device Time”) : https://www.connectiondocs.com/resources Substack (Weekly Articles on Connection): https://substack.com/@connectiondocs Breath & Body Regulation Training Tool: https://webekalm.com/ webe Pärents Podcast https://webekalm.com/pages/webeparents AI Connection Coach:https://app.kinectin.com/signup Main Book WELLNESS TO WONDERFUL: 9 Pillars for Living Healthier, Longer, and with Greater Joy: https://www.amazon.com/dp/B0C2S1JGZK?ref=cm_sw_r_ffobk_cso_sms_apin_dp_K6HM5P02NNK5WAMRGE87&ref_=cm_sw_r_ffobk_cso_sms_apin_dp_K6HM5P02NNK5WAMRGE87&social_share=cm_sw_r_ffobk_cso_sms_apin_dp_K6HM5P02NNK5WAMRGE87&starsLeft=1&skipTwisterOG=1&bestFormat=true Children's E-Books (Supporting Children Bringing More Connection Into Their Lives): Healing Shame and Connecting to Self-Worth and Intrinsic Value: https://webekalm.com/products/lily-and-her-beautiful-flower Being Honest with Care https://webekalm.com/products/ella-and-the-two-gifts-ebook Supporting Children During Emergencies (fires, earthquakes, etc):'https://webekalm.com/products/brave-hearts-facing-the-fire-ebook Social Media: Instagram: https://www.instagram.com/TheConnectionDocs Substack Newsletter: https://connectionDocs.substack.com Facebook: https://www.facebook.com/connectionDocs X: https://x.com/connectionDocs
Send us Fan MailA cancer diagnosis can change everything in an instant. One conversation. Three words: "You have cancer." Suddenly, patients and families are faced with uncertainty, fear, and countless questions about what comes next.In this episode of MedStar Health DocTalk, host Debra Schindler sits down with medical oncologist and hematologist Dr. Ankit Madan of MedStar Southern Maryland Hospital Center, to discuss the critical first steps after a cancer diagnosis. Dr. Madan explains how patients move from diagnosis to treatment, how cancer is staged, and why building a multidisciplinary care team is essential for the best possible outcomes.The conversation explores the emotional impact of hearing a cancer diagnosis, the importance of patient navigators, social workers, nutritionists, mental health professionals, and the role patients play as active partners in their own care. Dr. Madan also discusses treatment advances, clinical trials, immunotherapy breakthroughs, second opinions, and practical advice for patients and families navigating one of life's most challenging journeys.Whether you or a loved one has recently been diagnosed with cancer, this episode offers guidance, reassurance, and expert insight into what happens after the diagnosis—and how patients can move forward with confidence and support.Topics covered:• Coping with the emotional impact of a cancer diagnosis• Understanding cancer staging and treatment planning• The role of biopsies, CT scans, PET scans, and additional testing• Building a multidisciplinary cancer care team• Patient navigators, social workers, and support services• Shared decision-making and patient autonomy• When to seek a second opinion• Clinical trials and emerging cancer treatments• Immunotherapy and advances in cancer care• Nutrition, exercise, and mental health during treatment• Cancer survivorship and ongoing surveillanceTo learn more about cancer care at MedStar Health, visit MedStarHealth.org/Cancer.For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.
Prostate cancer treatment can bring lasting physical and emotional changes — and many men are caught off guard by how long recovery actually takes. Here is what to expect and how peer support helps. To learn more, visit https://prostaid.org/meetings/ Prostaid Calgary City: Calgary Address: 1600 90 Avenue Southwest Website: https://prostaid.org/
ChristianaCare researchers identified a developmental genetic pattern that showed how colorectal cancer develops. The findings revealed that certain types of genes drive cancer growth and resistance, and how the precise timing of how they develop is linked to colon cancer formation.The research team's work also showed the genes can predict survival in colorectal cancer patients, indicating it can be a marker of disease behavior and a target for future therapies.This week, Delaware Public Media's Joe Irizarry sat down with Bruce Boman, M.D., senior author of the study and senior researcher at ChristianaCare's Helen F. Graham Cancer Center & Research Institute to discuss this colorectal cancer research.
The latest episode of the DDW 'In Conversation With' series is available to listen to below. This week, Bruno Quinney speaks to Terry Connolly and Shinta Cheng from K36 Therapeutics. K36 is a company developing first-in-class cancer therapeutics and their current lead asset is a treatment for multiple myeloma patients. Bruno speaks to Terry and Shinta about how their NSD2 inhibitors can treat cancer, how their approach compares to other biotechs, and why K36's science could be applied to other therapeutic areas. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
Dr. Alicia Zhou is the Chief Executive Officer of the Cancer Research Institute—the oldest nonprofit in the world devoted exclusively to cancer immunology and immunotherapy. She joins Shoshana to discuss the innovations happening in cancer research, how immunotherapy is different from chemotherapy and radiation, what doctors can do to make clinical trials less intimidating, and why the conversation around cancer will change in the next 10 years. Hosted on Acast. See acast.com/privacy for more information.
A man is in jail this morning for shooting his pregnant, teenage girlfriend in Bay Park. Plus, another problem with a wastewater pipeline dumping sewage into the Tijuana River. And, researchers at U.C. San Diego are using AI to help create custom cancer treatments based on a patient's genetics. NBC 7's Sergio Flores has these stories and more, including meteorologist Brooke Martell's forecast for Sunday, May 31, 2026.
FCC Chairman Brendan Carr joins after Disney filed early license renewal applications for its broadcast stations at the agency's request. Then, Erin Brockovich discusses the environmental concerns around the data center buildout and a new map she created to help track them. Plus, we take a look at what to expect from the American Society of Clinical Oncology's annual meeting, which kicks off today. Squawk on the Street Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
From Episode #247: "Cancer and Fenbendazole: Could Parasites Be a Symptom, Not the Cause?"✨ Subscribe for the Full Episode: https://beyondlabels.supportingcast.fmFind Joel Here: www.polyfacefarms.comFind Sina Here: www.drsinamccullough.comFollow on InstagramFollow on XSubscribe on RumbleSubscribe on YouTubeDISCLAIMERGET 2DOT TICKETS HERE
Unpredictable weather is making it harder for amphibians to survive in West Virginia and elsewhere, but we learn about an effort to protect them. Also, the WVU Cancer Institute is enrolling pancreatic cancer patients for a promising, first-in-human clinical trial. The post Protecting Frogs And WVU Explores New Cancer Treatment, This West Virginia Morning appeared first on West Virginia Public Broadcasting.
- Overview of Bladder Cancer, Including Staging & Grading - Standard of Care - New Treatment Approaches - Update on Clinical Trials: How Research Increases Your Treatment Options - The Role of Diagnostic Technologies, Genomics & Precision Medicine - Targeted Treatments: Predicting Response to Treatment - The Role of Immunotherapy - Communicating with Your Health Care Team about Quality-of-Life Concerns - Follow-Up Care Appointments & Plans - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes - Nutrition & Hydration Concerns & Tips - Questions for Our Panel of Experts
Hyperbaric Oxygen Therapy (HBOT): Beyond the Bends—Wounds, Stroke Recovery, Radiation Injury, and Performance. Nicole Garrett, founder and COO of Under Pressure Hyperbarics, details hyperbaric oxygen therapy (HBOT). She explains how HBOT treats divers' decompression sickness by recompressing nitrogen bubbles and reducing inflammation, and how therapeutic benefits depend on reaching adequate pressure (commonly around 2.0 atmospheres or more; diver treatment may begin at 2.8). Garrett describes HBOT's history, FDA-approved uses such as diabetic wound healing, radiation injury, and sudden sensorineural hearing loss (often combined with steroids), and off-label use for stroke/TBI recovery, cognitive issues, autoimmune flares, Crohn's disease, athletic recovery, anti-aging research (including telomere findings), and adjunctive cancer care. She contrasts “soft” chambers with higher-pressure medical chambers, discusses treatment courses (often 10–60 sessions), safety and contraindications (ears, pneumothorax, retinal bubble procedures), and practical barriers like cost, insurance coverage, and facility/oxygen regulations.
This interview is disseminated on behalf of Medicus Pharma Ltd.In this episode of Stocks to Watch, we are joined by Medicus Pharma (NASDAQ: MDCX) Executive Chairman and CEO Dr. Raza Bokhari to discuss the company's promising Phase 2 results for SkinJect, its innovative skin cancer treatment, and what lies ahead for the company across oncology, rare diseases, and prostate cancer.Learn more about Medicus Pharma: https://medicuspharma.com/Watch the full YouTube interview here: https://youtu.be/4GZIBnS2KZ0And follow us to stay updated: https://www.youtube.com/GlobalOneMedia
Thanks for listening, and please follow us on Insta @NHPTalent and www.youtube.com/thePOZcast For all episodes, please check out www.thePOZcast.com This special episode is brought to you by our dear friends at Blood Cancer United. An organization very near and dear to me. I'm here to remind you to give to causes that make a difference. You want to help but you don't know where to start? Blood Cancer United is at the top of my list. They are the global leader in helping patients and families with blood cancer, and your dollars fund research, patient support, and advocacy. Please give today here: Thank you for supporting this important mission. Learn more and donate here: https://pages.lls.org/voy/nyc/nyclls26/aposner CHAPTERS: 00:00 – 500 Episodes: Introducing Geoffrey Rogow Adam opens the milestone episode, introduces Geoffrey Rogow — journalist, survivor, founder, author — and sets the tone for the most personal conversation in the show's seven-year history. 03:00 – Who Were You Before? The Person Before Treatment Geoffrey's life before diagnosis: 30 years old, living in New York and Sydney, feeling infallible, driven by professional ambition. And Adam's contrast — a father of two at 45, diagnosed only because he went to a cardiologist after his brother-in-law died. 07:00 – The Diagnosis: Two Very Different Moments Geoffrey's blood clot in the night that saved his life. Adam's cardiologist scan that caught a mass nobody expected. The two very different ways a diagnosis lands — one like a movie, one like a text message. 13:00 – Four Days vs. Six Weeks: The Window Before Treatment Geoffrey had four days between diagnosis and chemotherapy. Adam had six weeks. What that difference does to your mind, your fear, your processing — and why no two cancer stories are the same. 17:00 – The Thing Nobody Tells Young Adults: Fertility The Vanderbilt study that found 50% of young adults diagnosed with cancer are never told about their fertility options before treatment. Geoffrey's sperm banking story. Adam's moment of levity. The organizations that exist to help — and why you should use them. 23:00 – Chemotherapy: The Reality Nobody Films Steroids that make you feel like Batman. Fatigue that puts you to bed at 1 PM. The taste of treatment — Geoffrey's: a burning Nike Air Max. Adam's: Sour Patch Kids and Shrek's condom. The rhythm of treatment cycles and the crash that follows. 30:00 – Hair Loss: The Moment It Hits You Not just the hair on your head — all of it. Geoffrey's Jewish mohawk and the cat photos. Adam's man bun, the shower, the wall of clumps, the hairdresser call. Why the eyebrows and eyelashes are the part nobody prepares you for. 37:00 – Going Out in Public Without Eyebrows Geoffrey at his best friend's wedding, feeling like a freak. Adam at a bar mitzvah two weeks post-treatment, cancer beanie and all. Why "you look great" hits differently when you don't recognize yourself in the photos. 42:00 – Tribes, Villages & Crisis Language Geoffrey's lesson: his tribe was too small — just his wife and the cat. The mistake he'd change. Adam's: an oversharer married to a shield, learning to lean on his guy friends so his wife didn't have to carry everything. What "crisis language as a couple" actually means. 49:00 – Tolerance for Bullshit: The Larry David Effect What cancer does to your patience for other people's bravado. Geoffrey's bar story, running out into Times Square and crashing full speed into Elmo. The anger that's real, and the work it takes not to carry it forever. 55:00 – The Biannual Check-In: A Framework for Purposeful Change A scheduled, structured personal evaluation every six months — professional path, relationships, health, direction. The check-in that led Geoffrey to leave the Wall Street Journal after 21 years. Why you can't make the changes when the warning lights are flashing; you have to make them later, in clarity. 61:00 – Scanxiety: The Incurable Side Effect of Survivorship Geoffrey's scan is next Wednesday. He started thinking about it two weeks ago. The reality that scanxiety doesn't diminish with time — it sometimes gets worse. What helps, what stops helping, and why there's no permanent answer. 66:00 – After Treatment: The Part Nobody Celebrates The financial reality: bill negotiations, illegal anesthesiologist charges, state-specific protections, hospital programs for lower-income patients. Life insurance rejection at 35. Career decisions constrained by healthcare costs. The bills that arrive 18 months later asking "didn't I already pay this?" 73:00 – Ambition After Cancer: Don't Change the Level, Change the Lane The advice from career coach Michelle Woodward: keep the same level of ambition even if you have to find a different lane. Geoffrey's Hong Kong trip — the first time after treatment he felt like himself professionally again. Adam's silver lining of leaning into tech during treatment. 79:00 – Writing It Down: The Value of Documentation Adam's Super Whisper app diary — before and after every treatment session. Geoffrey's 14 years of running away from his cancer story, and what writing the book finally unlocked. Why every survivor should find their version of processing. 85:00 – I'm Alive: Now What? — The Book Geoffrey's nine-chapter guide for survivors — money, career, physical health, mental health, family planning, caregiving, purpose, the business of advice — built around real people's stories paired with expert guidance. Pre-order at after-treatment.com/the-book. 91:00 – Are You Getting the Support You Need? Geoffrey's question for Adam — and for every survivor. The cancer imposter syndrome that comes with a high-survival-rate diagnosis. Why you can't let anyone take away what you went through, and why the work doesn't end at remission. 97:00 – North Stars: What Keeps You Focused Geoffrey's: a willingness to change his North Star — short-term, practical, written down, evaluated regularly. Adam's: being the best example for his kids and leaving the world better than he found it. How cancer changes your definition of success. 104:00 – 500 Episodes: Thank You Adam closes the milestone episode with gratitude — for the guests, the listeners, seven years of consistency, and what comes next. TAKEAWAYS: 1. The Diagnosis Is Never Like the Movies — Except When It Is Geoffrey's came in an ER at 30. Adam's in a text from his cardiologist. No two stories are the same — but both changed everything. 2. 50% of Young Adult Cancer Patients Are Never Told About Fertility Options A Vanderbilt study found half of young adults aren't counseled on fertility preservation before treatment starts. The window is measured in days. Make sure this conversation happens first. 3. The Biannual Check-In Is the Most Powerful Tool for Purposeful Change Twice a year, scheduled, with a workbook: evaluate your path, relationships, and direction — in calm, not crisis. The check-in that led Geoffrey to leave 21 years at the Wall Street Journal. 4. Don't Change the Level of Your Ambition — Change the Lane If cancer takes away what you were world-class at, find another lane at the same level. Don't shrink. Redirect. That's not a lesser life — it's a different one. 5. Your Relationship With Time and Bullshit Changes — But Differently for Everyone Every survivor agrees on two things: time feels different, and their tolerance for bullshit has shifted. Geoffrey went full Larry David. Adam found unexpected clarity. The work is figuring out which version of you emerged. 6. Cancer Exposes Your Crisis Language as a Couple The couples who survive this well learn how to communicate what they need, what not to say, and what to let breathe. It's practiced, not instinctive. 7. Scanxiety Is Real, Incurable, and Changes Over Time What helped before may stop helping. Survivors need to plan for this, not be surprised by it. 8. The Financial Reckoning Comes Long After Treatment Ends Medical bills stay higher forever. Many are negotiable. Some are illegal. Own the advocacy, ask the questions, build the spreadsheet. 9. Write It Down — In Whatever Form Works for You Adam used Super Whisper before and after every treatment. Geoffrey wrote a book 14 years later. The form doesn't matter. Externalizing the experience gives you a time capsule you can go back to. 10. Are You Getting the Support You Need? Just the honest, periodic question. What you went through is not nothing — and the work doesn't end at remission. 11. You Are Different Now — Not Better or Worse. Different. Not better, not worse. Fundamentally changed in ways that can't be fully accounted for. That difference isn't a loss. The work is learning to live in the new timeline.
Dr. Robert Soiffer took an interest in medicine at an early age when he played a physician in his first-grade play. Today, he is a leading physician, researcher, and teacher at Dana-Farber Cancer Institute, a world leader in oncology. In this episode, Dr. Soiffer describes the incredible pace of change in the field of cancer research and treatment and the detection tools and cures that are right around the corner. He also reflects on how he maintains a positive and optimistic outlook despite the many times he's forced to deliver terrible news to patients and families. While he tries hard not to bring these tough times home with him, he also stresses the importance of keeping his humanity and treating his patients and their families as people, not just statistics. Chapters: 02:29 Dana-Farber's Special Mission Dr. Soiffer discusses what makes Dana-Farber Cancer Institute unique, emphasizing its focus on cancer patients and the common purpose among all staff. 05:50 Evolution of Cancer Treatment This segment details the seismic shift in cancer treatment over the past 40 years, from nonspecific chemotherapy to targeted therapies focusing on specific mutations. 10:25 Bone Marrow Transplants and Graft vs. Leukemia Dr. Soiffer delves into the history of bone marrow transplants, highlighting the Nobel Prize-winning work of E. Donald Thomas and the intriguing concept of graft versus leukemia effect. 15:02 The Role of Medical Education and Mentoring This chapter emphasizes the critical role of medical education and mentoring in shaping the future of medicine, drawing from Dr. Soiffer's experience as chief medical resident and mentor. He discusses the mutual learning process between experienced physicians and younger generations, and the importance of continuous learning. 19:50 Personal Impact of Oncology Work Dr. Soiffer reflects on the emotional challenges of his work, balancing optimism with realism and honesty while treating patients facing life-threatening situations. He discusses the difficulty of compartmentalizing emotions and the importance of maintaining humanity and connection with patients and their families, even when outcomes are not positive. 24:57 The Value of Clinical Trials This chapter explains the critical role of clinical trials in advancing cancer treatment, from early-stage phase I trials to comparative studies. Dr. Soiffer describes patients participating in these trials as brave pioneers, highlighting how targeted, immune, and cellular therapies would not exist without their contributions. 28:39 Global Collaboration in Medicine Dr. Soiffer discusses the extensive global collaboration in medical and scientific fields, emphasizing the shared mission to develop therapies for suffering patients. 35:33 Future of Cancer Treatment and Prevention Looking ahead, Dr. Soiffer predicts less toxic and more precise cancer treatments with improved therapeutic ratios, focusing on overcoming resistance and early detection. He discusses the potential of preventing progression to full-blown malignancy through early intervention and the growing understanding of germline predispositions to cancer. 41:26 Conclusion and Call to Optimism The episode concludes with Bill Burke thanking Dr. Soiffer for his time and invaluable insights, highlighting the rapid pace of change and innovation in cancer research. He also expresses hope and optimism for the future of cancer care.
Have you heard of Treatment-Induced Accelerated Aging (TIAA)? It's been called the Achilles' heel for cancer survivors. But what is it and more importantly, how can it be prevented or addressed? On this show, Karolyn talks with integrative oncologist Dr. Nathan Handley, Director of the Integrative Cancer Recovery Program at the Marcus Institute of Integrative Health at Jefferson Health in Pennsylvania. Because Dr. Handley specializes in cancer recovery, he is well-versed in addressing TIAA.Five To Thrive Live is broadcast live Tuesdays at 7PM ET and Music on W4CS Radio – The Cancer Support Network (www.w4cy.com) part of Talk 4 Radio (www.talk4radio.com) on the Talk 4 Media Network (www.talk4media.com).Five To Thrive Live Podcast is also available on Talk 4 Media (www.talk4media.com), Talk 4 Podcasting (www.talk4podcasting.com), iHeartRadio, Amazon Music, Pandora, Spotify, Audible, and over 100 other podcast outlets.
Register free at https://brightu.com to watch the full Beyond The Diagnosis stream Stay informed on current events, visit www.NaturalNews.com - Trump's Operation Freedom and Its Implications (0:11) - Trump's Tweet and the Confusion Over Operation Freedom (4:00) - The Realities of the Strait of Hormuz and Iran's Control (8:29) - The Impact of the Closed Strait of Hormuz on Global Food Supply (20:06) - Medication Spellbinding and Its Dangers (25:30) - The Role of Psychiatric Drugs in Altered Behavior (27:25) - The Spellbinding Effect of Psychiatric Drugs (32:11) - The Risks of Psychiatric Medication and Natural Alternatives (41:58) - The Future of BrighteLearn and Its Impact (51:28) - The Potential for UFO Disclosure and Its Implications (1:11:52) - FDA's Actions Against Healing Peptides and Light Therapy (1:19:20) - Jonathan Otto's Introduction and Red Light Therapy (1:23:35) - Scientific Basis of Light Therapy and Cancer Treatment (1:26:24) - Additional Light Therapy Applications and Preventive Measures (1:28:39) - Combining Light Therapy with Other Modalities (1:34:26) - Frequencies and Wavelengths in Light Therapy Devices (1:41:16) - Supply Chain Challenges and Product Availability (1:57:24) - Personal Testimonies and Real-World Applications (2:00:23) - Upcoming Event and Additional Resources (2:02:21) - Health Ranger Store Products and Final Remarks (2:04:10) Watch more independent videos at http://www.brighteon.com/channel/hrreport ▶️ Support our mission by shopping at the Health Ranger Store - https://www.healthrangerstore.com ▶️ Check out exclusive deals and special offers at https://rangerdeals.com ▶️ Sign up for our newsletter to stay informed: https://www.naturalnews.com/Readerregistration.html Watch more exclusive videos here:
Are biomarkers the missing link in personalized prostate cancer care? What is the practical role of biomarkers across the prostate cancer treatment continuum? In this episode of BackTable Urology, Dr. Udit Singhal (University of Michigan) joins Dr. Ruchika Talwar (Vanderbilt University) to explore the evolving role of genomic classifiers and biomarkers in prostate cancer care. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported byVeracytehttps://www.veracyte.com/decipher-prostate --- Timestamps 00:00 - Introduction04:58 - Current State10:07 - Interpreting High Risk Scores13:25 - Intermediate Risk Decisions16:18 - Imaging vs. Genomics18:26 - Advanced Disease Evidence22:02 - AI and Clinical Trials29:52 - Conclusions --- More about this episode They review commonly used assays, including Prolaris, Oncotype Dx, Decipher, and ConfirmMDx and emphasize how these tools complement traditional clinical and pathologic risk factors. The discussion highlights practical applications across the disease continuum from initial diagnosis and active surveillance to intermediate-risk management and post-prostatectomy salvage decisions. They also explore emerging AI-driven tools and ongoing trials, highlighting the importance of contextualizing biomarker data within the broader clinical picture and using it to inform, rather than dictate, patient-centered care. --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
Iran negotiations appear on the verge of collapse as the ceasefire deadline approaches, with U.S. officials preparing to travel for talks even as Iranian leadership signals it may not participate. Outrage is mounting after the IDF confirmed a soldier was responsible for smashing a statue of Jesus in southern Lebanon, prompting condemnation from Prime Minister Netanyahu and Christian leaders. FBI Director Kash Patel files a $250 million defamation lawsuit against The Atlantic, accusing the outlet of knowingly publishing false allegations about his conduct based on anonymous sources. A personalized mRNA vaccine for pancreatic cancer is showing early signs of promise in a small Phase 1 trial. California's governor's race is shifting following Eric Swalwell's exit amid scandal, with new polling showing former HHS Secretary Xavier Becerra gaining ground as a potential contender. Birch Gold: Text MK to 989898 to join Birch Gold's Learn and Earn event by April 30! Supersure Insurance: Simplify your business insurance and get a free coverage report at https://Supersure.com/Megyn Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
In this episode, we're joined by Katrina Foe as she shares her personal journey of overcoming breast cancer through a fully holistic, natural approach. Now a board-certified holistic and functional nutritionist, Katrina is a passionate advocate for addressing the root causes of disease through targeted nutrition, lifestyle changes, and functional medicine. What sets her approach apart? Katrina sits down to break down the philosophy behind her methods and how focusing on the body's internal environment can play a key role in supporting healing and long-term health…. Click play to discover: The role of diet and lifestyle in supporting the body during illness. Key principles for addressing root causes rather than symptoms. How Katrina's experience shaped her mission to help others take control of their health. The importance of testing when it comes to identifying cancer causes. Curious about how Katrina's journey from patient to practitioner has challenged conventional thinking and inspired others? Tune in to explore a different perspective on healing and what it can look like to take a more natural, integrative path. Connect with Katrina by visiting Cancerfreedom.com.